Global Analysis of BRAFV600E Target Genes in Human Melanocytes Identifies Matrix Metalloproteinase-1 As a Critical Mediator of Melanoma Growth

Overview

Journal J Invest Dermatol

Publisher Elsevier

Specialty Dermatology

Date 2011 Apr 1

PMID 21451543

Citations 10

Authors

Byungwoo Ryu

Whei F Moriarty

Megan J Stine

Amena DeLuca

Dave S Kim

Alan K Meeker

Landon D Grills

Rebecca A Switzer

Mark S Eller

Rhoda M Alani

Affiliations

Soon will be listed here.

Citing Articles

The classification of melanocytic gene signatures.

Hu M, Coleman S, Judson-Torres R, Tan A Pigment Cell Melanoma Res. 2024; 37(6):854-863.

PMID: 39072997 PMC: 11518649. DOI: 10.1111/pcmr.13189.

BRAF induces reversible mitotic arrest in human melanocytes via microrna-mediated suppression of AURKB.

McNeal A, Belote R, Zeng H, Urquijo M, Barker K, Torres R Elife. 2021; 10.

PMID: 34812139 PMC: 8610417. DOI: 10.7554/eLife.70385.

Oxidative Phosphorylation Promotes Primary Melanoma Invasion.

Salhi A, Jordan A, Bochaca I, Izsak A, Darvishian F, Houvras Y Am J Pathol. 2020; 190(5):1108-1117.

PMID: 32142731 PMC: 7237828. DOI: 10.1016/j.ajpath.2020.01.012.

The Aryl Hydrocarbon Receptor Is Expressed in Thyroid Carcinoma and Appears to Mediate Epithelial-Mesenchymal-Transition.

Moretti S, Nucci N, Menicali E, Morelli S, Bini V, Colella R Cancers (Basel). 2020; 12(1).

PMID: 31936153 PMC: 7016998. DOI: 10.3390/cancers12010145.

KIT Suppresses BRAF-Mutant Melanoma by Attenuating Oncogenic RAS/MAPK Signaling.

Neiswender J, Kortum R, Bourque C, Kasheta M, Zon L, Morrison D Cancer Res. 2017; 77(21):5820-5830.

PMID: 28947418 PMC: 5679278. DOI: 10.1158/0008-5472.CAN-17-0473.

References

Michaloglou C, Vredeveld L, Soengas M, Denoyelle C, Kuilman T, van der Horst C . BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature. 2005; 436(7051):720-4. DOI: 10.1038/nature03890. View

Davies H, Bignell G, Cox C, Stephens P, Edkins S, Clegg S . Mutations of the BRAF gene in human cancer. Nature. 2002; 417(6892):949-54. DOI: 10.1038/nature00766. View

Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A . PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell. 2005; 120(3):303-13. DOI: 10.1016/j.cell.2004.12.018. View

Blackburn J, Rhodes C, Coon C, Brinckerhoff C . RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis. Cancer Res. 2007; 67(22):10849-58. DOI: 10.1158/0008-5472.CAN-07-1791. View

Blackburn J, Liu I, Coon C, Brinckerhoff C . A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis. Oncogene. 2009; 28(48):4237-48. PMC: 2788659. DOI: 10.1038/onc.2009.272. View

Huntington J, Shields J, Der C, Wyatt C, Benbow U, Slingluff Jr C . Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling. J Biol Chem. 2004; 279(32):33168-76. DOI: 10.1074/jbc.M405102200. View

Ryu B, Kim D, DeLuca A, Alani R . Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS One. 2007; 2(7):e594. PMC: 1895889. DOI: 10.1371/journal.pone.0000594. View

Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M . Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol. 1997; 17(9):5598-611. PMC: 232408. DOI: 10.1128/MCB.17.9.5598. View

Zhang Q, Thomas S, Xi S, Smithgall T, Siegfried J, Kamens J . SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells. Cancer Res. 2004; 64(17):6166-73. DOI: 10.1158/0008-5472.CAN-04-0504. View

10.

Pollock P, Harper U, Hansen K, Yudt L, Stark M, Robbins C . High frequency of BRAF mutations in nevi. Nat Genet. 2002; 33(1):19-20. DOI: 10.1038/ng1054. View

11.

Hoek K, Schlegel N, Brafford P, Sucker A, Ugurel S, Kumar R . Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 2006; 19(4):290-302. DOI: 10.1111/j.1600-0749.2006.00322.x. View

12.

Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M . ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 2009; 23(16):1882-94. PMC: 2725946. DOI: 10.1101/gad.1824809. View

13.

Rodeck U, Melber K, Kath R, Menssen H, Varello M, Atkinson B . Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol. 1991; 97(1):20-6. DOI: 10.1111/1523-1747.ep12477822. View